Sofinnova Investments, Inc. Madrigal Pharmaceuticals, Inc. Transaction History

Sofinnova Investments, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$193.33 - $291.99 $4.91 Million - $7.41 Million	25,388 Added 133.42%	44,417 $12.4 Million
Q1 2024 Aug 14, 2024	SELL	$171.37 - $283.23 $4.35 Million - $7.19 Million	-25,388 Reduced 57.16%	19,029 $5.08 Million
Q1 2024 May 15, 2024	BUY	$171.37 - $283.23 $3.26 Million - $5.39 Million	19,029 New	19,029 $5.08 Million

296

22M

819K

640K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.94B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.